Posts

Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy

Irish Supreme Court in Merck v Clonmel puts "adequacy of damages" back in the balance when granting preliminary junctions

Fordham 27 (Report 1): Key Current IP Issues: Reflections & Analysis